Posts per subject

Erasmus MC has established a new company dedicated to developing a new form of immunotherapy. This new therapy — a personalized cancer vaccine — is intended for patients with pancreatic cancer.

Researchers from Erasmus MC have found a novel target for immunotherapy for an aggressive form of breast cancer. They isolated a receptor from white blood cells that recognizes the target and took the first steps towards a clinical treatment. “It was like searching for a needle in a haystack.”

A blood test can help to predict whether immunotherapy will be effective in patients with metastatic bladder cancer. This is evident from research by internist-oncologist Debbie Robbrecht from the Erasmus MC Cancer Institute.